Fatal refractory chronic active Epstein-Barr virus infection with hemophagocytic lymphohistiocytosis and NK/T-cell lymphoma: a case report
CAEBV is a rare and fatal complication of EBV. Clinician education, early recognition, and expert consultation improve outcomes. Treatment so far consists of chemotherapy followed by hematopoietic stem cell transplantation.
Authors
- Rima El-Herte (ORCID: https://orcid.org/0000-0002-6453-7830)
- Nicholas Mielke (ORCID: https://orcid.org/0000-0003-2461-427X)
- Marlaena Nicole Nooney
- Nagendra Natarajan
Institutions
- Creighton University (US)
- Nebraska Cancer Specialists (US)
Publication Details
- Journal
- ASM Case Reports
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1128/asmcr.00168-25
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00